New Prospects and Strategies for Drug Target Discovery in Neurodegenerative Disorders
AUTOR(ES)
Hilbush, Brian S.
FONTE
The American Society for Experimental NeuroTherapeutics
RESUMO
Summary: The future of neurodegenerative therapeutics development depends upon effective disease modification strategies centered on carefully investigated targets. Pharmaceutical research endeavors that probe for a much deeper understanding of disease pathogenesis, and explain how adaptive or compensatory mechanisms might be engaged to delay disease onset or progression, will produce the needed breakthroughs. Below, we discuss the prospects for new targets emerging out of the study of brain disease genes and their associated pathogenic pathways. We describe a general experimental paradigm that we are employing across several mouse models of neurodegenerative disease to elucidate molecular determinants of selective neuronal vulnerability. We outline key elements of our target discovery program and provide examples of how we integrate genomic technologies, neuroanatomical methods, and mouse genetics in the search for neurodegenerative disease targets.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1201320Documentos Relacionados
- Drug Discovery for Disorders of the Central Nervous System
- Drug discovery and computational strategies in the multitarget drugs era
- A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information
- Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
- Anti dermatophytic therapy: prospects for the discovery of new drugs from natural products
